Уноси
Search full-text
"Biljana Tubić"
-
Bevacizumab in combination with irinotecan and capecitabine as first-line tretment for mCRC-efficacy and safety (2014)
S. Jungić, Г. Кецман-Малчић, И. Ракита, Д. Јовановић, Р. Гајанин, З. Марић, Б. Тубић, З. Гојковић, Bevacizumab in combination with irinotecan and capecitabine as first-line tretment for mCRC-efficacy and safety, Annals of Oncology, 2014